FDA OKs Aloxi for Chemo-Induced Nausea, Vomiting in ChildrenFDA OKs Aloxi for Chemo-Induced Nausea, Vomiting in Children

The FDA has approved palonosetron HCL (Aloxi, Eisai Inc and Hensinn Group) injection for the prevention of chemotherapy-induced nausea and vomiting in children aged 1 month to less than 17 years. FDA Approvals

Source: Medscape Medical News Headlines - June 2, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news